Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm

Medicine and Dentistry

• Abdominal Aortic Aneurysm 100%
• Activating Transcription Factor 3 100%
• Vascular Smooth Muscle Cell 25%
• Promoter Region 15%
• Programmed Cell Death 10%
• Cell Proliferation 10%
• Enhancer Region 10%
• Tumor Necrosis Factor 10%
• Cardiovascular Disease 5%
• Diseases 5%
• Mitochondrion 5%
• RNA Sequence 5%
• Aneurysm 5%
• Smooth Muscle 5%
• Platelet Derived Growth Factor Receptor 5%
• Tissue Injury 5%
• Chromatin Immunoprecipitation 5%
• Serotype 5%
• Andrographolide 5%
• Angiotensin II 5%
• Muscle Protein 5%
• Adeno-Associated Virus 5%
• Short Hairpin RNA 5%
• Table Salt 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Abdominal Aortic Aneurysm 100%
• Activating Transcription Factor 3 100%
• Tumor Necrosis Factor 10%
• RNA-Sequencing 5%
• Disease 5%
• Aneurysm 5%
• Short Hairpin RNA 5%
• Tissue Injury 5%
• Adeno Associated Virus 5%
• Chromatin Immunoprecipitation 5%
• Andrographolide 5%
• Platelet Derived Growth Factor Receptor 5%
• Muscle Protein 5%
• Angiotensin II 5%
• Cardiovascular Disease 5%
• Table Salt 5%

Immunology and Microbiology

• Activating Transcription Factor 3 100%
• Vascular Smooth Muscle Cell 25%
• Promoter Region 15%
• Enhancer Region 10%
• Cell Proliferation 10%
• Tumor Necrosis Factor 5%
• Tumor Necrosis Factor Alpha 5%
• Serotype 5%
• Mitochondrion 5%
• Platelet Derived Growth Factor 5%
• RNA Sequence 5%
• PDGFRB 5%
• Smooth Muscle 5%
• Adeno Associated Virus 5%
• Chromatin Immunoprecipitation 5%